VP, Bioanalytical Development
- Expertise
- Services
- Solutions
- About Us
- Resources
Expertise
Services
Solutions
About Us
About Us- Overview
- Leadership
- Facility and Equipment
- Quality and Compliance
- Therapeutic Areas
- Why Us?
- Values
- Process
- Partners
- Careers
Business Development Associate
Sr. Scientist – Cell Based Assay
GLP Quality Assurance Manager
Sr. Scientist, ELISA Immunoassay Bioanalysis
Sr. Scientist, LC-MS/MS Bioanalysis
Associate Scientist, Central Laboratory Services
Sr. Scientist - Pharmacokinetics (PK)
Content Manager, Scientific and Regulatory Writing
Resources
Rigorous In-Vitro ADME Studies To Understand Pharmacokinetics (PK) Of Your Drug Compounds!
- ADME Pharmacokinetics For Metabolic Stability In Liver Microsomes And Other Applicable Biological Fractions
- Cytochrome P450 Inhibition, Induction, And Polymorphism To Assess Drug Safety And Food Or Drug Interaction ADME Studies
- Caco-2, MDCK-1, Or Pampa ADME Assays To Determine Gut, BBB, Or Cellular Permeability
- Plasma Protein Binding To Assess Circulating Free Drug Level In The Body
Regulated And Inspected By:
Provide Your Bioanalysis Study Details
We Will Respond Within 1 Business Day
Click below for answers to your ADME Studies questions -
Ask Us About Your Study
Customized ADME Studies to evaluate the disposition of your drug candidates within the body and select suitable drug compound with desirable DMPK properties.
What are ADME Studies?
ADME Studies: Measuring Drug Viability and Suitability for Later Development
The absorption, distribution, metabolism, and excretion (ADME) pharmacokinetics studies form an efficacy benchmark for various drug compounds. The evaluation of these pharmacological properties is critical for the selection of a new drug candidate during drug discovery and development.
ADME assays are conducted to make a go-no-go decision regarding drug candidate selection and movement into late-stage preclinical and clinical programs. Regular improvements in the ADME properties are achieved during lead optimization while keeping the selectivity and potency of the chemical drug lead intact. It, however, is plausible to have chemically efficacious compounds with acceptable ADME properties but decreased in vivo potencies.
Absorption
Drugs administered orally are absorbed in the digestive tract and reach the site of action through the bloodstream. The extent of drug absorption and corresponding concentration at the site of action is affected by various aspects such as reduced gastric emptying time, compound solubility, chemical instability, intestinal transit time, etc.
Absorption quality of a drug compound in ADME studies is primarily assessed to analyze the bioavailability of the drug at the site of action. If an orally administered drug is poorly absorbed in the systemic circulation in the human body, discrete methods of administration are tested, such as inhalation or intravenous intake. Hence, the route of drug administration plays an essential role in the identification of drug efficacy.
Distribution
Once absorbed, the drug compound is required to reach the site of action. From the bloodstream, the most common distribution medium, the drug compound reaches various organs and muscles.
Metabolism
Most small molecules transform into metabolites through metabolic breakdown involving specific enzymatic systems. Some metabolites are inert and while others are active. Thus, metabolism deactivates parent drug’s administered dose leading to a reduced drug impact in case of inactive metabolites. However, it enhances the bioavailability of the drug compound at the site of action if the metabolite is active.
Excretion
The body excretes metabolites and remaining drugs through the kidneys and other organs. If excretion is incomplete, the accumulation of foreign substances in the body can adversely influence various metabolic processes.
Toxicity
The ADME studies often include toxicity study as the last phase. It calculates the extent to which the administration of a drug compound can harm the human body or organisms. Here, organisms may refer to animal or organism substructure such as cells.
Sponsors Love Our Bioanalytical Laboratory Services For Top Quality And Industry Leading Turnaround
Connect With Us For A Reference Call With Them!
NorthEast BioLab is a responsive, collaborative, and reliable partner
We trust NorthEast BioLab to design and execute streamlined, impactful bioanalytical projects
We found their integrity as refreshing as readiness to provide creative scientific input and high-quality data
We have worked with NorthEast BioLab for over ten years given their commitment to highest quality bioanalytical data.
NorthEast BioLab tremendously supported us in reproducing our critical lab discoveries for drug metabolism
NorthEast BioLab always exceeds expectations on bioanalytical assay development, validation, and sample analysis.
“NorthEast BioLab goes the extra mile. We look forward to more meaningful collaborations.”
NorthEast BioLab offers a science-based, hands-on approach to the latest bioanalytical platforms
We are thrilled to complete our bioanalytical studies with their top quality and incredibly responsive team.
We worked closely to implement the most efficient and cost-effective bioanalytical assay for our PK Studies.
Our projects with NorthEast BioLab include successful method development, validation, stability studies during Clinical Phase I – IV studies.
NorthEast BioLab provides critical insight, and are compliant with regulatory standards and industry best practices. We highly recommend them and look forward to working together again.
Our latest successful study was a pivotal bioequivalence study, where samples from a cross-over study with about 100 volunteers needed swift analysis.
This study, same as all other bioanalytical studies, was completed with top quality and reporting standard with incredible responsiveness.
NorthEast BioLab’s scientists deliver high-quality data on time and within budget
Tackle Your ADME Studies With Our Veteran Team Now!
What are the various ADME Assay Development services doing Drug R&D?
ADME Studies offered by NorthEast BioLab
The in vitro and in vivo ADME studies offer a deep understanding of Pharmacokinetic (PK) properties of the selected drug candidates. Assessing the potential of the compound in the early drug development phases offer desirable efficacy and safety profile of the drug candidate.
The bioavailability of the drug compound is influenced by various factors such as permeability, solubility, metabolism, and protein binding. Different ADME assays are utilized to determine the bioavailability of the given test sample such as protein binding assays, aqueous solubility, etc.
Metabolism, on the other hand, proves the therapeutic index of the compound by use of ADME assays such as cytochrome P450 induction and inhibition assays, UGT phenotyping, etc.
The ADME assays used for in vitro and in vivo studies as under:
- Aqueous solubility
- Lipophilicity (Log D) and Log P
- CaCo-2 and MDCK permeability
- PAMPA
- Plasma and serum stability
- Liver microsomes stability
- CYP Time-dependent inhibition
- CYP450 inhibition
- CYP450 phenotyping
- Blood-plasma distribution
- Plasma protein binding
- Brain protein binding
Registered And Inspected By Various Regulatory Agencies
Don’t Wait, Start Your ADME Studies Service Today!
Why choose NorthEast BioLab for Your ADME Studies?
Fit-for-purpose ADME Studies from your Screening Assays to Regulatory Submissions
The assessment of ADME pharmacokinetics is critical for various stages of drug development, such as discovery, preclinical, and clinical phases. ADME and toxicity studies offer a clear knowledge of the metabolism and safety profile of a feasible drug candidate, enabling proper execution of clinical trials. However, it is necessary to conduct these studies in a controlled environment, which is why our scientists rely on their industry knowledge and FDA approved standards for the in vivo and in vitro studies.
Owing to our in-depth understanding of the right drug development process, we even collaborate with your other vendors to ensure complete transparency. From the drug candidate selection based on various ADME pharmacokinetic factors to drug compound assessment in human volunteer or in vivo trials, our lab scientists and analysts closely monitor the therapeutic index of the drug compound. This objective lens helps ensure that the selected drug compound has the correct, safe concentration required for therapeutic effect at the site of action for an illness or disease.
The Basics of Bioanalysis
Bioanalysis is an essential tool in drug discovery and development for determining the concentration of drugs and their metabolites as well as various pharmacodynamics biomarkers in biological fluids. In these analyses, scientists use developed an….
What is the role of Plasma Protein Binding Assay in ADME Studies?
Plasma Protein Binding Assay in ADME Studies: Free drug at the target site vs. metabolism and elimination
The binding pattern of the drug compound to the plasma proteins are a major contributing factor to the distribution and overall efficacy of the drug. Generally, the drug concentration at the site of action is limited when the binding between plasma protein and drug compound is sturdy. Hence, the efficacy of the corresponding compound also reduces. Thus, understanding the impact of free drug in the plasma or plasma protein binding is necessary for drug discovery as assists in finding the associated in vivo efficacy of the drug product.
The degree of plasma protein binding of a drug compound can be determined using Rapid Equilibrium Dialysis (RED). Plasma spiked with the drug is placed in the central chamber of the RED device, and the isotonic sodium phosphate solution is placed in the peripheral chamber. The sample is incubated at 37 °C for 4 hours, and the free compound equilibrium is attained by diffusing unbound compound through the dialysis membrane of the RED device.
